Human Healthy Aging Nutrition

NucleoPals™: Nucleotide-Based Nutrition for Healthy Aging Innovation

NucleoPals™ is not positioned as a single-function ingredient. It is a nucleotide-centered nutrition platform developed for brands exploring science-based healthy aging, functional nutrition, precision nutrition, and longevity nutrition concepts.

What Is NucleoPals™?

A Systematic Nutrition Concept Built Around Nucleotides

NucleoPals™ is Zhen-Ao Bio-Tech’s human healthy aging nutrition concept built around yeast-derived 5′-nucleotides. It is designed to support formulation discussions related to cellular maintenance, metabolic balance, and healthy aging nutrition.

Unlike traditional single-benefit nutrition ingredients, NucleoPals™ follows a broader Geronutrition framework. It connects nucleotide availability with biological processes that are relevant to healthy aging research and functional nutrition innovation.

Supported by Scientific Research

From Nucleotide Nutrition Research to Healthy Aging Exploration

The development of NucleoPals™ builds on long-term research into nucleotide nutrition and emerging scientific interest in healthy aging biomarkers.

In human healthy aging research, nucleotide nutrition has been studied in randomized, double-blind, placebo-controlled settings involving older adult populations. These studies provide scientific context for further research and formulation exploration.

Regulatory note: Research summaries are provided for scientific and B2B ingredient communication only. They do not constitute disease diagnosis, treatment, cure, prevention, aging reversal, or lifespan-extension claims.

Research Context

Application Directions

Built for the Next Generation of Functional Nutrition Products

NucleoPals™ may be considered for brands developing healthy aging nutrition products, functional nutrition concepts, senior nutrition supplements, premium functional foods, and nutrition beverage systems.

It can also support exploratory work in precision nutrition and biomarker-informed product development, depending on local regulations, formulation design, and claim substantiation.

Finished-product positioning, dosage, labeling, and consumer-facing claims must be reviewed according to each target market’s regulatory requirements.

Potential Product Formats

Built on ZABT’s Nucleotide Manufacturing Platform

From Yeast Fermentation to Traceable Nucleotide Ingredients

NucleoPals™ relies on ZABT’s long-standing platform in yeast fermentation, RNA extraction, enzymatic conversion, nucleotide purification, crystallization, drying, and quality control.

This integrated platform helps support stable supply, batch-to-batch consistency, technical documentation, and customer formulation needs.

Responsible Global Communication

Scientific Positioning with Clear Regulatory Boundaries

NucleoPals™ is intended for B2B ingredient, formulation, and scientific communication. It is not presented as a medicine, disease-management product, or guaranteed physiological intervention.

This page does not claim that NucleoPals™ diagnoses, treats, cures, or prevents disease. It also does not claim to reverse aging, extend lifespan, or replace professional medical or nutritional guidance.

Customers should evaluate finished-product claims according to local laws, product category, formulation, dosage, intended population, label language, and available substantiation.